Reed Elsevier (LON: REL)‘s stock had its “overweight” rating restated by analysts at JPMorgan Chase in a research report issued to clients and investors on Wednesday. They currently have a $10.89 (675 GBX) price target on the stock.

A number of other analysts have also recently weighed in on REL. Analysts at Sanford C. Bernstein upgraded shares of Reed Elsevier to an “underperform” rating in a research note to investors on Monday. They now have a $6.45 price target on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Reed Elsevier in a research note to investors on Monday, September 3rd. They now have a $10.08 price target on the stock. Finally, analysts at HSBC reiterated an “overweight” rating on shares of Reed Elsevier in a research note to investors on Friday, August 31st. They now have a $10.71 price target on the stock.

Shares of Reed Elsevier opened at 597.00 on Wednesday. Reed Elsevier has a 52 week low of GBX 461.70 and a 52 week high of GBX 671.21. The company’s market cap is £7.188 billion.

Reed Elsevier PLC is a provider of professional information solutions. As of December 31, 2011, the Company was organized in five business segments: Elsevier, providing scientific, technical and medical information solutions; LexisNexis Risk Solutions, providing risk information and analytics to business and government customers; LexisNexis Legal & Professional, providing legal, tax, regulatory and business information solutions to professionals, business and government customers; Reed Exhibitions, organising trade exhibitions and conferences, and Reed Business Information, providing information and marketing solutions to business professionals.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.